News Agency
Men's Weekly

Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults

  • Written by PR Newswire
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults
  • Nuvaxovid™ is New Zealand's first and only protein-based COVID-19 vaccine
  • Nuvaxovid™ can now be used as a first or second booster dose for adults aged 18 and older vaccinated with any primary series vaccine

GAITHERSBURG, Md., Aug. 17, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and...

Read more: Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a...

The Role of Stainless Steel Suppliers in Australia’s Industry

Stainless steel has become a cornerstone of modern industry, valued for its strength, durability, and resistance to corrosion. From construction and manufacturing to kitchenware and medical equipment, stainless steel plays a vital role in countless applications. Central to this supply... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion